Screener
Novavax NVAX Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Novavax’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
FAQ
- What is Novavax's finance lease liabilities?
- Novavax (NVAX) reported finance lease liabilities of $1.72M in Q2 2026.
- How has Novavax's finance lease liabilities changed year-over-year?
- Novavax's finance lease liabilities decreased by 96.7% year-over-year, from $52.37M to $1.72M.
- What is the long-term trend for Novavax's finance lease liabilities?
- Over 5 years (2020 to 2025), Novavax's finance lease liabilities has grown at a -44.6% compound annual growth rate (CAGR), from $40.08M to $2.09M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Novavax's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude